Sign up & Download
Sign in

Drug evaluation: tagatose in the treatment of type 2 diabetes and obesity.

by M C Moore
Curr Opin Investig Drugs ()


Spherix Inc (formerly Biospherics) is developing tagatose, an orally active\nlactose derivative for the potential treatment of obesity and type 2 diabetes.\nThe compound is also under investigation for the potential treatment of anemia,\nhemophilia and medical problems related to infertility, birth weight and\nexcessive maternal food intake. Phase I and II clinical trials have been\ncompleted.

Cite this document (BETA)

Readership Statistics

1 Reader on Mendeley
by Discipline
by Academic Status
100% Ph.D. Student

Sign up today - FREE

Mendeley saves you time finding and organizing research. Learn more

  • All your research in one place
  • Add and import papers easily
  • Access it anywhere, anytime

Start using Mendeley in seconds!

Sign up & Download

Already have an account? Sign in